Table 3: Presence of cutaneous
manifestations as predictive factor other clinical manifestations.
|
With Cutaneous manifestations |
Without Cutaneous manifestations |
Univariable Analyses |
Multivariable
Analyses* |
|||
OR (95% CI) |
p value |
OR (95% CI) |
p Value |
||||
Clinical Manifestations, n (%) |
Systemic |
181 (44.2) |
45 (54.2) |
0.679 (0.423-1.091) |
0.117 |
|
|
Musculoskeletal |
58 (42.0) |
24 (49.0) |
0.755 (0.393-1.453) |
0.408 |
|
|
|
Ocular |
126 (10.7) |
27 (13.5) |
0.770 (0.493-1.203) |
0.273 |
|
|
|
Pleuropulmonary |
133 (12.9) |
35 (22.4) |
0.490 (0.322-0.744) |
0.002 |
0.519 (0.372-0.724) |
0.001 |
|
Cardiac |
116 (10.3) |
22 (13.0) |
0.764 (0.471-1.248) |
0.283 |
|
|
|
Renal |
299 (36.0) |
46 (39.0) |
0.880 (0.592-1.307) |
0.540 |
|
|
|
Neurological |
277 (25.4) |
41 (22.7) |
1.161 (0.799-1.687) |
0.460 |
|
|
|
Hematologic |
314 (52.0) |
53 (70.7) |
0.449 (0.267-0.758) |
0.002 |
0.621 (0.440-0.876) |
0.002 |
*Variables
included in step 1: gender, age at diagnosis and clinical manifestations.